39355003|t|Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy.
39355003|a|Epilepsy and Alzheimer's disease share some common pathologies such as neurodegeneration, seizures and impaired cognition. However, the molecular mechanisms of these changes are still largely unknown. Fyn, a Src-family non-receptor tyrosine kinase (SFK), and its interaction with tau in mediating brain pathology in epilepsy and Alzheimer's disease can be a potential therapeutic target for disease modification. Although Fyn and tau pathology occurs in both Alzheimer's disease and epilepsy, the dynamics of Fyn-tau and PSD95-NR2B interactions affected by seizures and their impact on brain pathology in epilepsy have not been investigated. In this study, we demonstrate a significant increase of Fyn-tau interactions following seizure induction by kainate in both acute and chronic rodent models and in human epilepsy. In the early phase of epileptogenesis, we show increased Fyn/tau/NR2B/PSD95/neuronal nitric oxide synthase complexes after status epilepticus and a postsynaptic increase of phosphorylated tau (pY18 and AT8), Fyn (pSFK-Y416), NMDAR (pNR2B-Y1472) and neuronal nitric oxide synthase. Hippocampal proximity ligation assay and co-immunoprecipitation revealed a sustained increase of Fyn-tau and NR2B-PSD95 complexes/binding in rat chronic epilepsy at 3 months post-status epilepticus. Enhanced Fyn-tau complexes strongly correlated with the frequency of spontaneously recurring convulsive seizures and epileptiform spikes in the chronic epilepsy model. In human epileptic brains, we also identified increased Fyn-tau and NR2B-PSD95 complexes, tau phosphorylation (pY18 and AT8) and Fyn activation (pSFK-Y416), implying the translational and therapeutic potential of these molecular interactions. In tau knockout mice and in rats treated with a Fyn/SFK inhibitor saracatinib, we found a significant reduction of phosphorylated Fyn, tau (AT8 in saracatinib-treated), NR2B and neuronal nitric oxide synthase and their interactions (Fyn-tau and NR2B-PSD95 in saracatinib-treated group; NR2B-PSD95 in tau knockout group). The reduction of Fyn-tau and NR2B-PSD95 interactions in the saracatinib-treated group, in contrast to the vehicle-treated group, correlated with the modification in seizure progression in the rat chronic epilepsy model. These findings from animal models and human epilepsy provide evidence for the role of Fyn-tau and NR2B-PSD95 interactions in seizure-induced brain pathology and suggest that blocking such interactions could modify the progression of epilepsy.
39355003	9	12	Fyn	Gene	2534
39355003	13	16	tau	Gene	4137
39355003	21	25	NR2B	Gene	2904
39355003	26	31	PSD95	Gene	1742
39355003	48	57	epileptic	Disease	MESH:D004827
39355003	90	95	human	Species	9606
39355003	96	104	epilepsy	Disease	MESH:D004827
39355003	106	114	Epilepsy	Disease	MESH:D004827
39355003	119	138	Alzheimer's disease	Disease	MESH:D000544
39355003	177	194	neurodegeneration	Disease	MESH:D019636
39355003	196	204	seizures	Disease	MESH:D012640
39355003	209	227	impaired cognition	Disease	MESH:D003072
39355003	307	310	Fyn	Gene	2534
39355003	386	389	tau	Gene	4137
39355003	422	430	epilepsy	Disease	MESH:D004827
39355003	435	454	Alzheimer's disease	Disease	MESH:D000544
39355003	528	531	Fyn	Gene	2534
39355003	536	539	tau	Gene	4137
39355003	565	584	Alzheimer's disease	Disease	MESH:D000544
39355003	589	597	epilepsy	Disease	MESH:D004827
39355003	615	618	Fyn	Gene	2534
39355003	619	622	tau	Gene	4137
39355003	627	632	PSD95	Gene	1742
39355003	633	637	NR2B	Gene	2904
39355003	663	671	seizures	Disease	MESH:D012640
39355003	711	719	epilepsy	Disease	MESH:D004827
39355003	804	807	Fyn	Gene	25150
39355003	808	811	tau	Gene	4137
39355003	835	842	seizure	Disease	MESH:D012640
39355003	856	863	kainate	Chemical	MESH:D007608
39355003	911	916	human	Species	9606
39355003	917	925	epilepsy	Disease	MESH:D004827
39355003	984	987	Fyn	Gene	25150
39355003	988	991	tau	Gene	4137
39355003	992	996	NR2B	Gene	2904
39355003	997	1002	PSD95	Gene	1742
39355003	1050	1068	status epilepticus	Disease	MESH:D013226
39355003	1115	1118	tau	Gene	4137
39355003	1135	1138	Fyn	Gene	2534
39355003	1305	1308	Fyn	Gene	25150
39355003	1309	1312	tau	Gene	4137
39355003	1317	1321	NR2B	Gene	24410
39355003	1322	1327	PSD95	Gene	29495
39355003	1349	1352	rat	Species	10116
39355003	1361	1369	epilepsy	Disease	MESH:D004827
39355003	1387	1405	status epilepticus	Disease	MESH:D013226
39355003	1416	1419	Fyn	Gene	25150
39355003	1420	1423	tau	Gene	4137
39355003	1500	1519	convulsive seizures	Disease	MESH:D012640
39355003	1524	1543	epileptiform spikes	Disease	MESH:D031261
39355003	1559	1567	epilepsy	Disease	MESH:D004827
39355003	1578	1583	human	Species	9606
39355003	1584	1593	epileptic	Disease	MESH:D004827
39355003	1631	1634	Fyn	Gene	2534
39355003	1635	1638	tau	Gene	4137
39355003	1643	1647	NR2B	Gene	2904
39355003	1648	1653	PSD95	Gene	1742
39355003	1665	1668	tau	Gene	4137
39355003	1704	1707	Fyn	Gene	2534
39355003	1821	1824	tau	Gene	4137
39355003	1834	1838	mice	Species	10090
39355003	1846	1850	rats	Species	10116
39355003	1866	1869	Fyn	Gene	2534
39355003	1884	1895	saracatinib	Chemical	MESH:C515233
39355003	1948	1951	Fyn	Gene	25150
39355003	1953	1956	tau	Gene	4137
39355003	1965	1976	saracatinib	Chemical	MESH:C515233
39355003	1987	1991	NR2B	Gene	2904
39355003	2051	2054	Fyn	Gene	2534
39355003	2055	2058	tau	Gene	4137
39355003	2063	2067	NR2B	Gene	2904
39355003	2068	2073	PSD95	Gene	1742
39355003	2077	2088	saracatinib	Chemical	MESH:C515233
39355003	2104	2108	NR2B	Gene	2904
39355003	2109	2114	PSD95	Gene	1742
39355003	2118	2121	tau	Gene	4137
39355003	2156	2159	Fyn	Gene	2534
39355003	2160	2163	tau	Gene	4137
39355003	2168	2172	NR2B	Gene	2904
39355003	2173	2178	PSD95	Gene	1742
39355003	2199	2210	saracatinib	Chemical	MESH:C515233
39355003	2304	2311	seizure	Disease	MESH:D012640
39355003	2331	2334	rat	Species	10116
39355003	2343	2351	epilepsy	Disease	MESH:D004827
39355003	2397	2402	human	Species	9606
39355003	2403	2411	epilepsy	Disease	MESH:D004827
39355003	2445	2448	Fyn	Gene	2534
39355003	2449	2452	tau	Gene	4137
39355003	2457	2461	NR2B	Gene	2904
39355003	2462	2467	PSD95	Gene	1742
39355003	2484	2491	seizure	Disease	MESH:D012640
39355003	2592	2600	epilepsy	Disease	MESH:D004827
39355003	Negative_Correlation	MESH:C515233	2904
39355003	Negative_Correlation	MESH:C515233	MESH:D000544
39355003	Negative_Correlation	MESH:C515233	25150
39355003	Positive_Correlation	MESH:D007608	MESH:D012640
39355003	Association	MESH:D031261	25150
39355003	Association	MESH:D004827	2904
39355003	Association	MESH:D000544	2534
39355003	Association	2534	4137
39355003	Association	MESH:D004827	25150
39355003	Negative_Correlation	MESH:C515233	2534
39355003	Association	MESH:D004827	4137
39355003	Association	24410	29495
39355003	Association	MESH:D013226	25150
39355003	Association	1742	2904
39355003	Bind	1742	4137
39355003	Positive_Correlation	MESH:D007608	25150
39355003	Positive_Correlation	MESH:D012640	25150
39355003	Negative_Correlation	MESH:C515233	MESH:D012640
39355003	Association	1742	2534
39355003	Association	MESH:D013226	4137
39355003	Association	MESH:D000544	4137
39355003	Association	MESH:D004827	1742
39355003	Association	MESH:D031261	4137
39355003	Negative_Correlation	MESH:C515233	1742
39355003	Association	MESH:D004827	2534
39355003	Bind	25150	4137

